Pirfenidone Tablets IP is an antifibrotic medicine used to slow the progression of idiopathic pulmonary fibrosis and decline in lung function.
Key Benefits
- Used in the management of idiopathic pulmonary fibrosis
- Helps slow the progression of lung fibrosis
- May help reduce the rate of decline in lung function
- Supports long-term management of chronic pulmonary fibrosis
- Helps control processes involved in excessive scar tissue formation
How It Works
Pirfenidone has antifibrotic and anti-inflammatory properties. It helps reduce the production of substances involved in inflammation and fibrosis, which may slow the formation and progression of scar tissue in the lungs.
Common Side Effects
- Nausea
- Diarrhea
- Indigestion
- Loss of appetite
- Fatigue
- Headache
- Dizziness
- Skin rash
- Increased sensitivity to sunlight
- Changes in liver function
Important Information
Pirfenidone Tablets IP should be used under the supervision of a qualified healthcare professional. Liver function tests may be required before and during treatment. Avoid excessive exposure to sunlight and use appropriate sun protection, as pirfenidone can increase sensitivity to sunlight. Inform your doctor about liver or kidney problems and all medicines you are taking. Seek medical advice if severe skin reactions, persistent gastrointestinal symptoms, or signs of liver problems occur.